Table 2.
Characteristics of included studies (Shoulder pain with movement dysfunction sub-category)
| Study(Author,Year, Design) | Participants (n, M:F, Age) | Experimental intervention |
Comparator intervention |
Dose | Outcome measures and Time points | Main Findings |
|---|---|---|---|---|---|---|
| Kachingwe 2008, Pilot RCT | Exp: n = 9, 5:4, 48.9 (13.7) | MWM + Exercise | 1. Kaltenborn mobilization + Exercise 2. Exercise 3. Control |
1 per week x 6 weeks | ROM, Pain intensity, SPADI. Baseline, 3 weeks | No significant difference in any outcome between the groups post intervention |
| 1. Con: n = 9, 4:5, 43.4 (14.7) | ||||||
| 2. Con: n = 8, 4:4, 47.3 (20.1) | ||||||
| 3. Con: n = 7, 4:3 45.6 (13.0) | ||||||
| Djordjevic 2012, RCT | Exp: n = 10, 4:6, 51.80 (5.3) | MWM + kinesiotaping | Exercise | 10 sessions | ROM. Baseline, 5 & 10 days |
Significant improvement in ROM for MWM + kinesiotaping group compared to control group |
| Con: n = 10, 3:7, 54.10 (6.8) | ||||||
| Srivastava 2018, RCT | Exp: n = 11, NA, 50.09 (11.36) | MWM + Exercise | Cryotherapy + Exercise | 6 sessions | ROM, Pain intensity, SPADI. Baseline, after 1st and 6th intervention | No significant difference in any outcome for MWM group compared to Cryotherapy group |
| Con: n = 11, NA, 41.91 (11.22) | ||||||
| Delgado 2015, RCT | Exp: n = 21, 4:17, 55.4 (7.8) | MWM | Sham | 2per week X 2 weeks | ROM, Pain intensity. Baseline, 2 weeks |
Significant improvement in all outcomes for MWM group compared to sham group |
| Con: n = 21, 4:17, 54.3 (10) | ||||||
| Guimarães 2016, Crossover RCT | Exp: n = 14, 6:8, NA | MWM | Sham | 4 x sessions to crossover 48 hours apart | ROM, Pain intensity, SPADI, DASH, Muscle strength. Baseline, after 4x sessions (around 8–10 days) | No significant difference in any outcome for MWM group compared to sham group |
| Con: n = 13, 6:7, NA | ||||||
| Teys 2006, Crossover RCT | n = 24,11:3, 46.1 (9.86) | MWM | Sham control |
3 sessions | ROM, pressure pain threshold. Baseline – 3 sessions with 24 hr interval | Significant improvement in all outcomes for MWM group compared to sham and control group |
| Exp: n = 15, 11:4, 40.23 (10.55) | ||||||
| Neelapala 2016, RCT | Con: n = 16, 12:4, 42.41 (10.38) | MWM + Exercise | Exercise | 3 sessions | Pain, muscle strength, Scapular upward rotation. Baseline, after 3 sessions |
Significant improvement in pain and external rotation strength for MWM group compared to control group |
| Romero 2015, Pilot RCT | Exp: n = 22, 11:11, 84.7 (8.7) | MWM + postural advice + Exercise | Postural advice + Exercise | 3 per week x 2 weeks | Baseline, 2 weeks, 1 and 3 months | No significant between and within groups differences in any outcome |
| Con: n = 22, 11:11, 83.1 (7.8) | ||||||
| Satpute 2015, RCT | Exp: n = 22, 10:12, 53.41 (7.08) | MWM+ Exercise + Heat | Exercise + Heat | 3 per week X 3 weeks | ROM, Pain intensity, SPADI, Baseline, 3 weeks | Significant improvement in all outcomes for MWM group compared to control group |
| Con: n = 22,15:7, 52.41 (7.06) | ||||||
| Subhash 2020, RCT | Exp: n = 16, NA, 30.87 (9.37) | MWM + Exercise + Heat | Exercise + Heat | 6 sessions over 2 weeks | ROM, Pain intensity, SPADI, Baseline, 2 weeks | Significant improvement in pain intensity and flexion ROM for MWM group compared to control group. No significant difference between groups for any other outcomes |
| Con: n = 16, NA, 32.37 (9.74) | ||||||
| Menek 2019, RCT | Exp: n = 15, 8:7, 51.73 (6.64) | MWM+ Exercise + Cryotherapy + TENS+US | Exercise + Cryotherapy + TENS+US | 5 per week X 6 weeks | ROM, Pain intensity, DASH, SF-36 Base line, 6 weeks |
Significant improvement in all outcomes for MWM group compared to control group |
| Con: n = 15, 10:5, 50.26 (4.28) |
Exp: Experimental group, Con: Control group, RCT: Randomized clinical trial, MWM: Mobilization with movement, ROM: range of motion, SPADI: Shoulder Pain and Disability Index, TENS: Transcutaneous electrical nerve stimulation, DASH: Disability of Arm Shoulder and Hand, NA: Not available, US: Ultrasound, VAS: Visual analogue scale, SF-36: Short Form-36.